Overview
Autoimmunity in Retinitis Pigmentosa
Status:
Unknown status
Unknown status
Trial end date:
1969-12-31
1969-12-31
Target enrollment:
0
0
Participant gender:
All
All
Summary
Using local immune suppression, the trial seeks evidence for the hypothesis that autoimmunity plays a role in the pathomechanism of retinitis pigmentosa.Phase:
N/ADetails
Lead Sponsor:
Semmelweis UniversityTreatments:
Cyclosporine
Cyclosporins
Ophthalmic Solutions
Criteria
Inclusion Criteria:- Clinical diagnosis of retinitis pigmentosa
Exclusion Criteria:
- Cataract
- Extremely low ERG wave amplitude (less than 8% of normal)